EP Patent

EP2349238B1 — Co-crystals of tramadol and nsaids

Assigned to Esteve Pharmaceuticals SA · Expires 2016-08-24 · 10y expired

What this patent protects

Patent listed against Celebrex.

Drugs covered by this patent

Celebrex (celecoxib) · Pfizer Inc. (originally Searle/Pharmacia)

Patent Metadata

Patent number: EP2349238B1
Jurisdiction: EP
Classification: —
Expires: 2016-08-24
Drug substance claim: No
Drug product claim: No
Assignee: Esteve Pharmaceuticals SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.